Treatments in Phase 1 Trials
Biologics
Name: CC-90006
Indication: Psoriasis
- Celgene
- PD-1 Agonist Antibody
Name: MSB11022
Indication: Psoriasis
- EMD Serono
- Biosimilar for Humira (adalimumab)
- TNF-alpha inhibitor
Oral Treatments
Name: ABBV-157
Indication: Psoriasis
- Abbvie
- RoRγT Inhibitor
Name: CC-92252
Indication: Psoriasis
- Celgene
- Interleukin-2 receptor agonists; Regulatory T-lymphocyte stimulants
Name: EDP1066
Indication: Psoriasis
- Evelo Biosciences
- Monoclonal microbial
Name: EDP1815
Indication: Psoriasis
- Evelo Biosciences, Inc.
- Monoclonal microbial
Topicals
Name: BOS-475
Indication: Psoriasis
- Boston Pharmaceuticals
- Selective BET (Bromodomain and Extra-Terminal) inhibitor